This alteration in smad3 phosphorylation, a key downstream effect of TGF-β1 signaling, provides additional evidence of the connection between tau hyperphosphorylation and the TGF-β1 pathway in the development of cardiac remodeling in T2DM. Here, SMAD3 is linked to type 2 diabetes mellitus.